Literature DB >> 9971755

pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion.

C Cianci1, K L Yu, D D Dischino, W Harte, M Deshpande, G Luo, R J Colonno, N A Meanwell, M Krystal.   

Abstract

The hemagglutinin (HA) protein undergoes a low-pH-induced conformational change in the acidic milieu of the endosome, resulting in fusion of viral and cellular membranes. A class of compounds that specifically interact with the HA protein of H1 and H2 subtype viruses and inhibit this conformational change was recently described (G. X. Luo et al., Virology 226:66-76, 1996, and J. Virol. 71:4062-4070, 1997). In this study, purified HA trimers (bromelain-cleaved HA [BHA]) are used to examine the properties and binding characteristics of these inhibitors. Compounds were able to inhibit the low-pH-induced change of isolated trimers, as detected by resistance to digestion with trypsin. Protection from digestion was extremely stable, as BHA-inhibitor complexes could be incubated for 24 h in low pH with almost no change in BHA structure. One inhibitor was prepared as a radiolabeled photoaffinity analog and used to probe for specific drug interactions with the HA protein. Analysis of BHA after photoaffinity analog binding and UV cross-linking revealed that the HA2 subunit of the HA was specifically radiolabeled. Cross-linking of the photoaffinity analog to BHA under neutral (native) pH conditions identified a stretch of amino acids within the alpha-helix of HA2 that interact with the inhibitor. Interestingly, cross-linking of the analog under acidic conditions identified a different region within the HA2 N terminus which interacts with the photoaffinity compound. These attachment sites help to delineate a potential binding pocket and suggest a model whereby the BHA is able to undergo a partial, reversible structural change in the presence of inhibitor compound.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9971755      PMCID: PMC104417     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide.

Authors:  S G Lazarowitz; P W Choppin
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

Review 2.  Unpacking the incoming influenza virus.

Authors:  A Helenius
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

Review 3.  Membrane fusion.

Authors:  J M White
Journal:  Science       Date:  1992-11-06       Impact factor: 47.728

4.  Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin.

Authors:  N K Sauter; G D Glick; R L Crowther; S J Park; M B Eisen; J J Skehel; J R Knowles; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

Review 5.  Viral and cellular membrane fusion proteins.

Authors:  J M White
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

6.  Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion.

Authors:  R W Ruigrok; A Aitken; L J Calder; S R Martin; J J Skehel; S A Wharton; W Weis; D C Wiley
Journal:  J Gen Virol       Date:  1988-11       Impact factor: 3.891

Review 7.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

8.  Fusion activity of influenza virus PR8/34 correlates with a temperature-induced conformational change within the hemagglutinin ectodomain detected by photochemical labeling.

Authors:  J Brunner; C Zugliani; R Mischler
Journal:  Biochemistry       Date:  1991-03-05       Impact factor: 3.162

9.  Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses.

Authors:  E Nobusawa; T Aoyama; H Kato; Y Suzuki; Y Tateno; K Nakajima
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

10.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.

Authors:  W Weis; J H Brown; S Cusack; J C Paulson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

View more
  13 in total

1.  Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion.

Authors:  Christopher Cianci; David R Langley; Douglas D Dischino; Yaxiong Sun; Kuo-Long Yu; Anne Stanley; Julia Roach; Zhufang Li; Richard Dalterio; Richard Colonno; Nicholas A Meanwell; Mark Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-06       Impact factor: 11.205

2.  Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.

Authors:  Xin Zhao; Runfeng Li; Yang Zhou; Mengjie Xiao; Chunlong Ma; Zhongjin Yang; Shaogao Zeng; Qiuling Du; Chunguang Yang; Haiming Jiang; Yanmei Hu; Kefeng Wang; Chris Ka Pun Mok; Ping Sun; Jianghong Dong; Wei Cui; Jun Wang; Yaoquan Tu; Zifeng Yang; Wenhui Hu
Journal:  J Med Chem       Date:  2018-06-11       Impact factor: 7.446

3.  Design and synthesis of benzenesulfonamide derivatives as potent anti-influenza hemagglutinin inhibitors.

Authors:  Guozhi Tang; Xianfeng Lin; Zongxing Qiu; Wentao Li; Lei Zhu; Lisha Wang; Shaohua Li; Haodong Li; Wenbin Lin; Mei Yang; Tao Guo; Li Chen; Daniel Lee; Jim Z Wu; Wengang Yang
Journal:  ACS Med Chem Lett       Date:  2011-06-07       Impact factor: 4.345

4.  Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.

Authors:  Evelien Vanderlinden; Fusun Göktas; Zafer Cesur; Matheus Froeyen; Mark L Reed; Charles J Russell; Nesrin Cesur; Lieve Naesens
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

5.  GS-5806 inhibits pre- to postfusion conformational changes of the respiratory syncytial virus fusion protein.

Authors:  Dharmaraj Samuel; Weimei Xing; Anita Niedziela-Majka; Jinny S Wong; Magdeleine Hung; Katherine M Brendza; Michel Perron; Robert Jordan; David Sperandio; Xiaohong Liu; Richard Mackman; Roman Sakowicz
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

6.  Orally active fusion inhibitor of respiratory syncytial virus.

Authors:  Christopher Cianci; Kuo-Long Yu; Keith Combrink; Ny Sin; Bradley Pearce; Alan Wang; Rita Civiello; Stacey Voss; Guangxiang Luo; Kathy Kadow; Eugene V Genovesi; Brian Venables; Hatice Gulgeze; Ashok Trehan; Jennifer James; Lucinda Lamb; Ivette Medina; Julia Roach; Zheng Yang; Lisa Zadjura; Richard Colonno; Junius Clark; Nicholas Meanwell; Mark Krystal
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

7.  Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion.

Authors:  Sudha Thoennes; Zhu-Nan Li; Byeong-Jae Lee; William A Langley; John J Skehel; Rupert J Russell; David A Steinhauer
Journal:  Virology       Date:  2007-10-23       Impact factor: 3.616

8.  Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin.

Authors:  Lei Zhu; Yuhuan Li; Shaohua Li; Haodong Li; Zongxing Qiu; Chichang Lee; Henry Lu; Xianfeng Lin; Rong Zhao; Li Chen; Jim Z Wu; Guozhi Tang; Wengang Yang
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

Review 9.  Small Molecule Inhibitors of Influenza Virus Entry.

Authors:  Zhaoyu Chen; Qinghua Cui; Michael Caffrey; Lijun Rong; Ruikun Du
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18

10.  Inhibition of influenza H7 hemagglutinin-mediated entry.

Authors:  Aleksandar Antanasijevic; Han Cheng; Duncan J Wardrop; Lijun Rong; Michael Caffrey
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.